Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects

Table 3

Linear regression analyses of log₁₀ PAI-1 in all study participants.

Variable
Age	0.098	0.38
Body mass index	0.578	<0.001
Waist circumference	0.579	<0.001
Lipid parameters
Log10 triglyceride	0.421	<0.001
Total cholesterol	−0.167	0.14
VLDL subfraction	0.284	0.01
Midband (IDL) subfraction	−0.482	<0.001
LDL-C	0.074	0.51
Apolipoprotein B	−0.078	0.51
Log10 large LDL subfraction	0.382	<0.001
Log10 small-dense LDL subfraction	0.315	0.01
Mean LDL size	−0.447	<0.001
HDL-C	−0.5	<0.001
Apolipoprotein AI	−0.426	<0.001
Log10 large HDL subfraction	−0.569	<0.001
Log10 intermediate HDL subfraction	−0.523	<0.001
Log10 small HDL subfraction	0.177	0.11
Inflammatory markers
Log10 hsCRP	0.444	<0.001
Log10 interleukin-6	0.485	<0.001
Log10 tumor necrosis factor-α	0.223	<0.05
Oxidative stress markers
Oxidized LDL	0.171	0.13
Log10 PON1 paraoxonase activity	−0.157	0.16
PON1 arylesterase activity	−0.194	0.09
Log10 myeloperoxidase	0.129	0.26

HDL: high-density lipoprotein; hsCRP: high-sensitivity C-reactive protein; LDL: low-density lipoprotein; PON1: paraoxonase-1.